Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications

Toyoshi Yanagihara, Ciaran Scallan, Kjetil Ask, Martin R.J. Kolb

Research output: Contribution to journalReview articlepeer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science